Canada Allocates $5M to Expand HIV Self-Testing and Peer Support Services
Event summary
- Canada invests $5 million to enhance HIV prevention and support services, focusing on self-testing kits and peer support workers.
- Funding aims to reach populations with the highest HIV burdens and barriers to care, including Indigenous communities and racialized groups.
- Approximately 7,000 Canadians living with HIV are unaware of their status, with 2,300 new diagnoses reported in 2024.
- The investment supports Canada's commitment to global HIV targets, aiming to eliminate HIV/AIDS as a public health threat by 2030.
- Two HIV self-test kits, INSTI and OraQuick, are currently approved in Canada, with OraQuick requiring an oral swab and INSTI a finger prick.
The big picture
Canada's $5 million investment in HIV self-testing and peer support services underscores a strategic shift toward decentralized, community-based healthcare. This aligns with broader global efforts to eliminate HIV/AIDS as a public health threat by 2030, addressing disparities in access to testing and treatment. The focus on key populations, including Indigenous communities and racialized groups, highlights the government's commitment to health equity and stigma reduction.
What we're watching
- Execution Risk
- Whether the $5 million investment will effectively reduce barriers to HIV testing and care in underserved communities.
- Regulatory Alignment
- How Canada's efforts align with global targets set by the Joint United Nations Programme on HIV/AIDS and the World Health Organisation.
- Stigma Reduction
- The pace at which peer support services can mitigate stigma and improve early diagnosis rates among key populations.
Related topics